Kureshi Alvena K, Funderburgh James L, Daniels Julie T
Ocular Biology & Therapeutics, Institute of Ophthalmology, University College London, London, United Kingdom.
Department of Ophthalmology, UPMC Eye Centre, University of Pittsburgh, Pittsburgh, Pennsylvania, United States.
Invest Ophthalmol Vis Sci. 2014 Oct 21;55(11):7583-8. doi: 10.1167/iovs.14-14448.
To assess the suitability of human donor corneas maintained in long-term organ culture for the isolation and expansion of viable and functional corneal stromal stem cells (CSSCs). These cells display properties similar to mesenchymal stem cells and demonstrate the ability to reproduce an organized matrix in vitro. Therefore, CSSCs have great potential for the development of cell-based therapies for corneal blindness or stromal tissue bioengineering.
Human donor corneas that had been stored either in organ-culture medium (OC) up to 4 weeks (n = 3) or in Optisol medium (OS) up to 6 days (n = 3) were used for isolation of CSSCs and maintained in culture until passage 4. Cell phenotype of isolated CSSCs was assessed with light microscopy and immunocytochemistry (PAX6, CD73, and CD90). PAX6 protein expression was further confirmed with immunoblot analysis.
A comparison of CSSCs isolated from corneas stored under OC and OS conditions revealed no obvious differences in their morphology. Immunocytochemistry revealed CSSCs from both OC and OS corneas maintained positive staining for PAX6 and mesenchymal stem cell markers CD73 and CD90. Immunoblotting confirmed protein expression of PAX6 in cells from both tissue types.
Human CSSCs exhibit survival capacity by retaining their phenotype following isolation from long storage, OC corneas. This advantageous property enables the retrieval of CSSCs from OC corneas that are more abundantly available for research than OS-stored corneas. Organ-culture corneas are also often discarded for retrieval of other cell types, such as corneal epithelial and endothelial cells, which require high tissue quality for their preservation.
评估长期器官培养保存的人类供体角膜用于分离和扩增有活力且功能正常的角膜基质干细胞(CSSCs)的适用性。这些细胞表现出与间充质干细胞相似的特性,并在体外展示出重现有组织基质的能力。因此,CSSCs在角膜盲细胞疗法或基质组织生物工程的发展中具有巨大潜力。
将在器官培养基(OC)中保存长达4周(n = 3)或在Optisol培养基(OS)中保存长达6天(n = 3)的人类供体角膜用于CSSCs的分离,并在培养中维持至第4代。通过光学显微镜和免疫细胞化学(PAX6、CD73和CD90)评估分离的CSSCs的细胞表型。通过免疫印迹分析进一步确认PAX6蛋白表达。
比较从OC和OS条件下保存的角膜中分离的CSSCs,发现它们的形态没有明显差异。免疫细胞化学显示,来自OC和OS角膜的CSSCs对PAX6以及间充质干细胞标志物CD73和CD90均保持阳性染色。免疫印迹证实两种组织类型的细胞中均有PAX6蛋白表达。
人类CSSCs从长期保存的OC角膜中分离后通过保持其表型展现出存活能力。这一有利特性使得能够从OC角膜中获取CSSCs,而OC角膜比OS保存的角膜在研究中更易于获得。器官培养角膜也常常因用于获取其他细胞类型(如角膜上皮细胞和内皮细胞,它们的保存需要高质量的组织)而被丢弃。